John W. Townsend's most recent trade in Unicycive Therapeutics Inc was a trade of 10,000 Stock Options done . Disclosure was reported to the exchange on July 28, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Unicycive Therapeutics Inc | John W. Townsend | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jul 2025 | 10,000 | 101,557 | - | - | Stock Options | |
| Unicycive Therapeutics Inc | John W. Townsend | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Aug 2024 | 40,256 | 915,565 | - | - | Stock Options | |
| Unicycive Therapeutics Inc | John W. Townsend | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Apr 2024 | 228,119 | 875,309 | - | - | Stock Options | |
| Unicycive Therapeutics Inc | John W. Townsend | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Aug 2023 | 570,329 | 647,190 | - | - | Stock Options | |
| Unicycive Therapeutics Inc | John W. Townsend | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Nov 2022 | 35,000 | 76,861 | - | - | Stock Options | |
| Unicycive Therapeutics Inc | John W. Townsend | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2021 | 18,605 | 41,861 | - | - | Stock Options |